Marcela M. Cordero Garcia

Array ( [id] => 6007503 [patent_doc_number] => 20110059534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'DETERMINATION OF TESTOSTERONE BY MASS SPECTROMETRY' [patent_app_type] => utility [patent_app_number] => 12/946785 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9777 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059534.pdf [firstpage_image] =>[orig_patent_app_number] => 12946785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968636 [patent_doc_number] => 08507447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Treatments for gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 12/942887 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15180 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985655 [patent_doc_number] => 20110097797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Modular Functional Peptides for the Intracellular Delivery of Nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/908601 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14911 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097797.pdf [firstpage_image] =>[orig_patent_app_number] => 12908601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685259 [patent_doc_number] => 20130053543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'PEPTIDE CLEARING AGENTS' [patent_app_type] => utility [patent_app_number] => 13/497967 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12458 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675469 [patent_doc_number] => 08383582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Inhibitor against forming biofilm comprising κ-casein macropeptide' [patent_app_type] => utility [patent_app_number] => 12/889402 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 6028 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12889402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977684 [patent_doc_number] => 20110071079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'SELF-ASSEMBLING POLY(DIOL CITRATES)-PROTEIN HYDROGELS' [patent_app_type] => utility [patent_app_number] => 12/887251 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071079.pdf [firstpage_image] =>[orig_patent_app_number] => 12887251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189826 [patent_doc_number] => 20110172167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'FORMULATIONS OF DAPTOMYCIN' [patent_app_type] => utility [patent_app_number] => 12/884653 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4803 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172167.pdf [firstpage_image] =>[orig_patent_app_number] => 12884653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738044 [patent_doc_number] => 08409814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Sensor proteins and assay methods' [patent_app_type] => utility [patent_app_number] => 12/874140 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22602 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12874140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351158 [patent_doc_number] => 20100331245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PEPTIDE YY ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/872584 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16178 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331245.pdf [firstpage_image] =>[orig_patent_app_number] => 12872584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201683 [patent_doc_number] => 08188247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Conjugates and compositions for cellular delivery' [patent_app_type] => utility [patent_app_number] => 12/871750 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26828 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188247.pdf [firstpage_image] =>[orig_patent_app_number] => 12871750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937981 [patent_doc_number] => 20110213123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 12/871800 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22517 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213123.pdf [firstpage_image] =>[orig_patent_app_number] => 12871800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174145 [patent_doc_number] => 20110177047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/861593 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 22186 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177047.pdf [firstpage_image] =>[orig_patent_app_number] => 12861593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10024991 [patent_doc_number] => 09066870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/851600 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7958 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024191 [patent_doc_number] => 20110052517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Cosmetic Uses of Modified Stressed Yeast Extracts and Related Compositions' [patent_app_type] => utility [patent_app_number] => 12/850193 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22185 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052517.pdf [firstpage_image] =>[orig_patent_app_number] => 12850193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669160 [patent_doc_number] => 20110318429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum' [patent_app_type] => utility [patent_app_number] => 12/826230 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6820 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12826230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127164 [patent_doc_number] => 08575113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'BIR domain binding compounds' [patent_app_type] => utility [patent_app_number] => 12/825197 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32842 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12825197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772412 [patent_doc_number] => 08426368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Method of ameliorating oxidative stress and supplementing the diet' [patent_app_type] => utility [patent_app_number] => 12/818807 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10401 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12818807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128359 [patent_doc_number] => 20120088730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'USE OF ANGIOTENSIN CONVERTING ENZYME (ACE) DOMAIN SPECIFIC INHIBITORS TO INHIBIT OR ENHANCE CYTOKINE PRODUCTION AND ALTER IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/375301 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8418 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088730.pdf [firstpage_image] =>[orig_patent_app_number] => 13375301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097452 [patent_doc_number] => 20110003753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/791356 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13794 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003753.pdf [firstpage_image] =>[orig_patent_app_number] => 12791356 [rel_patent_id] =>[rel_patent_doc_number] =>)